Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies
- PMID: 24978384
- DOI: 10.1038/ki.2014.144
Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies
Comment in
-
The authors reply.Kidney Int. 2014 Jul;86(1):211. doi: 10.1038/ki.2014.150. Kidney Int. 2014. PMID: 24978385 No abstract available.
Comment on
-
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.Kidney Int. 2012 Apr;81(8):727-32. doi: 10.1038/ki.2011.500. Epub 2012 Feb 15. Kidney Int. 2012. PMID: 22336988 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
